These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36070083)

  • 1. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mouse Model for Eosinophilic Esophagitis (EoE).
    Dsilva A; Avlas S; Rhone N; Itan M; Munitz A
    Curr Protoc; 2024 Feb; 4(2):e993. PubMed ID: 38372429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue remodeling in eosinophilic esophagitis.
    Cheng E; Souza RF; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
    Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
    J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
    Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
    J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.
    Rochman M; Travers J; Abonia JP; Caldwell JM; Rothenberg ME
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
    Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Ko E; Chehade M
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
    Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
    Shoda T; Wen T; Caldwell JM; Ben-Baruch Morgenstern N; Osswald GA; Rochman M; Mack LE; Felton JM; Abonia JP; Arva NC; Atkins D; Bonis PA; Capocelli KE; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Putnam PE; Rudman Spergel AK; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME;
    Gastroenterology; 2022 Feb; 162(2):439-453. PubMed ID: 34687736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal epithelial
    Clevenger MH; Wei C; Karami AL; Tsikretsis LE; Carlson DA; Pandolfino JE; Gonsalves N; Winter DR; Whelan KA; Tétreault MP
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13.
    Niranjan R; Rayapudi M; Mishra A; Dutt P; Dynda S; Mishra A
    Immunol Cell Biol; 2013 Jul; 91(6):408-15. PubMed ID: 23689305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73
    Hara T; Kasagi Y; Wang J; Sasaki M; Aaron B; Karami A; Shimonosono M; Shimonosono R; Maekawa H; Dolinsky L; Wilkins B; Klein J; Wei J; Nunes K; Lynch K; Spergel JM; Hamilton KE; Ruffner MA; Karakasheva TA; Whelan KA; Nakagawa H; Muir AB
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1449-1467. PubMed ID: 35108658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
    Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
    PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice.
    Venturelli N; Lexmond WS; Ohsaki A; Nurko S; Karasuyama H; Fiebiger E; Oyoshi MK
    J Allergy Clin Immunol; 2016 Nov; 138(5):1367-1380.e5. PubMed ID: 27233150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus.
    Ben Baruch-Morgenstern N; Mingler MK; Stucke E; Besse JA; Wen T; Reichman H; Munitz A; Rothenberg ME
    J Immunol; 2016 Aug; 197(3):707-14. PubMed ID: 27324131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.